Therapeutic application of RNA interference for hepatitis C virus

Advanced Drug Delivery Reviews

Volumn 59, Issue 12, 2007, Pages 1263-1276

  Watanabe, Tsunamasa ^a,b   Umehara, Takuya ^a   Kohara, Michinori ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Delivery; Escape; HCV; RNAi; siRNA; Therapeutics

Indexed keywords

CELLS; DISEASES; DRUG DELIVERY; GENES; MEDICAL IMAGING; TRANSCRIPTION; VIRUSES;

ANTIVIRAL THERAPY; MAMMALIAN CELLS; POST TRANSCRIPTIONAL GENES; THERAPEUTIC APPLICATIONS;

RNA;

DICER; DOUBLE STRANDED RNA; EXPORTIN 5; INTERFERON; RIBONUCLEASE; RIBOZYME; RNA INDUCED SILENCING COMPLEX; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

5' UNTRANSLATED REGION; BASE PAIRING; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG TARGETING; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENOTYPE; HEPATITIS C VIRUS; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; RNA INTERFERENCE; RNA SEQUENCE; VIRUS MUTATION; VIRUS REPLICATION;

ANIMALS; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS C; HUMANS; MODELS, BIOLOGICAL; MUTATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 35648962359     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.03.022     Document Type: Review

References (147)

1. Hepatitis C-global prevalence (update). Wkly. Epidemiol. Rec. 75 (2000) 18-19
2. Chander G., Sulkowski M.S., Jenckes M.W., Torbenson M.S., Herlong H.F., Bass E.B., and Gebo K.A. Treatment of chronic hepatitis C: a systematic review. Hepatology 36 (2002) S135-S144
3. Miller R.H., and Purcell R.H. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 2057-2061
4. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P.J., et al. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2451-2455
5. Bartenschlager R., Frese M., and Pietschmann T. Novel insights into hepatitis C virus replication and persistence. Adv. Virus Res. 63 (2004) 71-180
6. Tsukiyama-Kohara K., Iizuka N., Kohara M., and Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J. Virol. 66 (1992) 1476-1483
7. Tanaka T., Lau J.Y., Mizokami M., Orito E., Tanaka E., Kiyosawa K., Yasui K., Ohta Y., Hasegawa A., Tanaka S., et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J. Hepatol. 23 (1995) 742-745
8. Bukh J., Miller R.H., and Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15 (1995) 41-63
9. Martell M., Esteban J.I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., and Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66 (1992) 3225-3229
10. Behrens S.E., Tomei L., and De Francesco R. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. 15 (1996) 12-22
11. Mittal V. Improving the efficiency of RNA interference in mammals. Nat. Rev., Genet. 5 (2004) 355-365
12. Sioud M. On the delivery of small interfering RNAs into mammalian cells. Exp. Opin. Drug Deliv. 2 (2005) 639-651
13. Ryther R.C., Flynt A.S., Phillips III J.A., and Patton J.G. siRNA therapeutics: big potential from small RNAs. Gene Ther. 12 (2005) 5-11
14. Hannon G.J., and Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 431 (2004) 371-378
15. Dorsett Y., and Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev., Drug Discov. 3 (2004) 318-329
16. Caplen N.J., and Mousses S. Short interfering RNA (siRNA)-mediated RNA interference (RNAi) in human cells. Ann. N. Y. Acad. Sci. 1002 (2003) 56-62
17. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
18. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
19. Gil J., and Esteban M. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5 (2000) 107-114
20. Katze M.G., He Y., and Gale Jr. M. Viruses and interferon: a fight for supremacy. Nat. Rev. 2 (2002) 675-687
21. Takaoka A., Hayakawa S., Yanai H., Stoiber D., Negishi H., Kikuchi H., Sasaki S., Imai K., Shibue T., Honda K., and Taniguchi T. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424 (2003) 516-523
22. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
23. Bernstein E., Caudy A.A., Hammond S.M., and Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409 (2001) 363-366
24. Hammond S.M., Bernstein E., Beach D., and Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404 (2000) 293-296
25. Sheth U., and Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300 (2003) 805-808
26. Lund E., Guttinger S., Calado A., Dahlberg J.E., and Kutay U. Nuclear export of microRNA precursors. Science 303 (2004) 95-98
27. Yi R., Qin Y., Macara I.G., and Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17 (2003) 3011-3016
28. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 (2004) 326-330
29. Ui-Tei K., Naito Y., Takahashi F., Haraguchi T., Ohki-Hamazaki H., Juni A., Ueda R., and Saigo K. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 32 (2004) 936-948
30. Amarzguioui M., and Prydz H. An algorithm for selection of functional siRNA sequences. Biochem. Biophys. Res. Commun. 316 (2004) 1050-1058
31. Takasaki S., Kotani S., and Konagaya A. An effective method for selecting siRNA target sequences in mammalian cells. Cell Cycle 3 (2004) 790-795
32. Yuan B., Latek R., Hossbach M., Tuschl T., and Lewitter F. siRNA selection server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 32 (2004) W130-W134
33. Chalk A.M., Wahlestedt C., and Sonnhammer E.L. Improved and automated prediction of effective siRNA. Biochem. Biophys. Res. Commun. 319 (2004) 264-274
34. Saetrom P., and Snove Jr. O. A comparison of siRNA efficacy predictors. Biochem. Biophys. Res. Commun. 321 (2004) 247-253
35. Santoyo J., Vaquerizas J.M., and Dopazo J. Highly specific and accurate selection of siRNAs for high-throughput functional assays. Bioinformatics 21 (2005) 1376-1382
36. Boese Q., Leake D., Reynolds A., Read S., Scaringe S.A., Marshall W.S., and Khvorova A. Mechanistic insights aid computational short interfering RNA design. Methods Enzymol. 392 (2005) 73-96
37. Overhoff M., Alken M., Far R.K., Lemaitre M., Lebleu B., Sczakiel G., and Robbins I. Local RNA target structure influences siRNA efficacy: a systematic global analysis. J. Mol. Biol. 348 (2005) 871-881
38. Brown K.M., Chu C.Y., and Rana T.M. Target accessibility dictates the potency of human RISC. Nat. Struct. Mol. Biol. 12 (2005) 469-470
39. Westerhout E.M., Ooms M., Vink M., Das A.T., and Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 33 (2005) 796-804
40. Ding Y., Chan C.Y., and Lawrence C.E. Sfold web server for statistical folding and rational design of nucleic acids. Nucleic Acids Res. 32 (2004) W135-W141
41. Luo K.Q., and Chang D.C. The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region. Biochem. Biophys. Res. Commun. 318 (2004) 303-310
42. Yiu S.M., Wong P.W., Lam T.W., Mui Y.C., Kung H.F., Lin M., and Cheung Y.T. Filtering of ineffective siRNAs and improved siRNA design tool. Bioinformatics 21 (2005) 144-151
43. Heale B.S., Soifer H.S., Bowers C., and Rossi J.J. siRNA target site secondary structure predictions using local stable substructures. Nucleic Acids Res. 33 (2005) e30
44. Overhoff M., Alken M., Far R.K., Lemaitre M., Lebleu B., Sczakiel G., and Robbins I. Local RNA target structure influences siRNA efficacy: a systematic global analysis. Cell 348 (2005) 871-881
45. Kim D.H., Behlke M.A., Rose S.D., Chang M.S., Choi S., and Rossi J.J. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23 (2005) 222-226
46. Siolas D., Lerner C., Burchard J., Ge W., Linsley P.S., Paddison P.J., Hannon G.J., and Cleary M.A. Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol. 23 (2004) 227-231
47. Hnatyszyn H.J. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir. Ther. 10 (2005) 1-11
48. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., and Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 (1999) 110-113
49. Blight K.J., Kolykhalov A.A., and Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science 290 (2000) 1972-1974
50. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
51. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
52. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9294-9299
53. Randall G., Grakoui A., and Rice C.M. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 235-240
54. Kapadia S.B., Brideau-Andersen A., and Chisari F.V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2014-2018
55. Wilson J.A., Jayasena S., Khvorova A., Sabatinos S., Rodrigue-Gervais I.G., Arya S., Sarangi F., Harris-Brandts M., Beaulieu S., and Richardson C.D. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2783-2788
56. Yokota T., Sakamoto N., Enomoto N., Tanabe Y., Miyagishi M., Maekawa S., Yi L., Kurosaki M., Taira K., Watanabe M., and Mizusawa H. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 4 (2003) 602-608
57. Seo M.Y., Abrignani S., Houghton M., and Han J.H. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J. Virol. 77 (2003) 810-812
58. Takigawa Y., Nagano-Fujii M., Deng L., Hidajat R., Tanaka M., Mizuta H., and Hotta H. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome. Microbiol. Immunol. 48 (2004) 591-598
59. Prabhu R., Vittal P., Yin Q., Flemington E., Garry R., Robichaux W.H., and Dash S. Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone. J. Med. Virol. 76 (2005) 511-519
60. Sen A., Steele R., Ghosh A.K., Basu A., Ray R., and Ray R.B. Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res. 96 (2003) 27-35
61. Kanda T., Steele R., Ray R., and Ray R.B. Small interfering RNA targeted to hepatitis C virus 5′ nontranslated region exerts potent antiviral effect. J. Virol. 81 (2007) 669-676
62. Ogata N., Alter H.J., Miller R.H., and Purcell R.H. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3392-3396
63. Okamoto H., Kojima M., Okada S., Yoshizawa H., Iizuka H., Tanaka T., Muchmore E.E., Peterson D.A., Ito Y., and Mishiro S. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190 (1992) 894-899
64. Drake J.W., and Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13910-13913
65. Boden D., Pusch O., Lee F., Tucker L., and Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77 (2003) 11531-11535
66. Das A.T., Brummelkamp T.R., Westerhout E.M., Vink M., Madiredjo M., Bernards R., and Berkhout B. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78 (2004) 2601-2605
67. Gitlin L., Karelsky S., and Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418 (2002) 430-434
68. Konishi M., Wu C.H., Kaito M., Hayashi K., Watanabe S., Adachi Y., and Wu G.Y. siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations. J. Viral Hepatitis 13 (2006) 756-761
69. Wilson J.A., and Richardson C.D. Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J. Virol. 79 (2005) 7050-7058
70. Kronke J., Kittler R., Buchholz F., Windisch M.P., Pietschmann T., Bartenschlager R., and Frese M. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J. Virol. 78 (2004) 3436-3446
71. Watanabe T., Sudoh M., Miyagishi M., Akashi H., Arai M., Inoue K., Taira K., Yoshiba M., and Kohara M. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Gene Ther. 13 (2006) 883-892
72. Gitlin L., Stone J.K., and Andino R. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J. Virol. 79 (2005) 1027-1035
73. Korf M., Meyer A., Jarczak D., Beger C., Manns M.P., and Kruger M. Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters. J. Viral Hepatitis 14 (2007) 122-132
74. De Francesco R., and Migliaccio G. Challenges and successes in developing new therapies for hepatitis C. Nature 436 (2005) 953-960
75. Zhang J., Yamada O., Sakamoto T., Yoshida H., Iwai T., Matsushita Y., Shimamura H., Araki H., and Shimotohno K. Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus. Virology 320 (2004) 135-143
76. Korf M., Jarczak D., Beger C., Manns M.P., and Kruger M. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. J. Hepatol. 43 (2005) 225-234
77. Henry S.D., van der Wegen P., Metselaar H.J., Tilanus H.W., Scholte B.J., and van der Laan L.J. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol. Ther. 14 (2006) 485-493
78. Ali N., and Siddiqui A. Interaction of polypyrimidine tract-binding protein with the 5′ noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J. Virol. 69 (1995) 6367-6375
79. Anwar A., Ali N., Tanveer R., and Siddiqui A. Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site-mediated translation initiation. J. Biol. Chem. 275 (2000) 34231-34235
80. Chung R.T., and Kaplan L.M. Heterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3′ terminus of hepatitis C viral RNA. Biochem. Biophys. Res. Commun. 254 (1999) 351-362
81. Gontarek R.R., Gutshall L.L., Herold K.M., Tsai J., Sathe G.M., Mao J., Prescott C., and Del Vecchio A.M. hnRNP C and polypyrimidine tract-binding protein specifically interact with the pyrimidine-rich region within the 3′NTR of the HCV RNA genome. Nucleic Acids Res. 27 (1999) 1457-1463
82. Ito T., and Lai M.M. Determination of the secondary structure of and cellular protein binding to the 3′-untranslated region of the hepatitis C virus RNA genome. J. Virol. 71 (1997) 8698-8706
83. Ito T., and Lai M.M. An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3′-untranslated sequence. Virology 254 (1999) 288-296
84. Izumi R.E., Valdez B., Banerjee R., Srivastava M., and Dasgupta A. Nucleolin stimulates viral internal ribosome entry site-mediated translation. Virus Res. 76 (2001) 17-29
85. Kruger M., Beger C., Li Q.X., Welch P.J., Tritz R., Leavitt M., Barber J.R., and Wong-Staal F. Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8566-8571
86. Spangberg K., Goobar-Larsson L., Wahren-Herlenius M., and Schwartz S. The La protein from human liver cells interacts specifically with the U-rich region in the hepatitis C virus 3′ untranslated region. J. Hum. Virol. 2 (1999) 296-307
87. Spangberg K., Wiklund L., and Schwartz S. Binding of the La autoantigen to the hepatitis C virus 3′ untranslated region protects the RNA from rapid degradation in vitro. J. Gen. Virol. 82 (2001) 113-120
88. Tsuchihara K., Tanaka T., Hijikata M., Kuge S., Toyoda H., Nomoto A., Yamamoto N., and Shimotohno K. Specific interaction of polypyrimidine tract-binding protein with the extreme 3′-terminal structure of the hepatitis C virus genome, the 3′X. J. Virol. 71 (1997) 6720-6726
89. Ali N., and Siddiqui A. The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2249-2254
90. Fukushi S., Okada M., Kageyama T., Hoshino F.B., Nagai K., and Katayama K. Interaction of poly(rC)-binding protein 2 with the 5′-terminal stem loop of the hepatitis C-virus genome. Virus Res. 73 (2001) 67-79
91. Hahm B., Kim Y.K., Kim J.H., Kim T.Y., and Jang S.K. Heterogeneous nuclear ribonucleoprotein L interacts with the 3′ border of the internal ribosomal entry site of hepatitis C virus. J. Virol. 72 (1998) 8782-8788
92. Kaminski A., Hunt S.L., Patton J.G., and Jackson R.J. Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA. RNA 1 (1995) 924-938
93. Yen J.H., Chang S.C., Hu C.R., Chu S.C., Lin S.S., Hsieh Y.S., and Chang M.F. Cellular proteins specifically bind to the 5′-noncoding region of hepatitis C virus RNA. Virology 208 (1995) 723-732
94. Harris D., Zhang Z., Chaubey B., and Pandey V.N. Identification of cellular factors associated with the 3′-nontranslated region of the hepatitis C virus genome. Mol. Cell Proteomics. 5 (2006) 1006-1018
95. Jarczak D., Korf M., Beger C., Manns M.P., and Kruger M. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. FEBS J. 272 (2005) 5910-5922
96. Bukh J., Purcell R.H., and Miller R.H. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4942-4946
97. Prabhu R., Garry R.F., and Dash S. Small interfering RNA targeted to stem-loop II of the 5′ untranslated region effectively inhibits expression of six HCV genotypes. Virol. J. 3 (2006) 100
98. Akashi H., Miyagishi M., Yokota T., Watanabe T., Hino T., Nishina K., Kohara M., and Taira K. Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA. Mol. Biosyst. 1 (2005) 382-390
99. Li K., Chen Z., Kato N., Gale Jr. M., and Lemon S.M. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 280 (2005) 16739-16747
100. Konstantinova P., de Vries W., Haasnoot J., ter Brake O., de Haan P., and Berkhout B. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene Ther. 13 (2006) 1403-1413
101. Nishitsuji H., Kohara M., Kannagi M., and Masuda T. Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration. J. Virol. 80 (2006) 7658-7666
102. Weinberg M.S., Ely A., Barichievy S., Crowther C., Mufamadi S., Carmona S., and Arbuthnot P. Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA. Mol. Ther. 15 (2007) 534-541
103. Naito Y., Ui-Tei K., Nishikawa T., Takebe Y., and Saigo K. siVirus: web-based antiviral siRNA design software for highly divergent viral sequences. Nucleic Acids Res. 34 (2006) W448-W450
104. Honda M., Beard M.R., Ping L.H., and Lemon S.M. A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J. Virol. 73 (1999) 1165-1174
105. Spahn C.M., Kieft J.S., Grassucci R.A., Penczek P.A., Zhou K., Doudna J.A., and Frank J. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science 291 (2001) 1959-1962
106. Kieft J.S., Zhou K., Jubin R., and Doudna J.A. Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA 7 (2001) 194-206
107. Kolupaeva V.G., Pestova T.V., and Hellen C.U. An enzymatic footprinting analysis of the interaction of 40S ribosomal subunits with the internal ribosomal entry site of hepatitis C virus. J. Virol. 74 (2000) 6242-6250
108. Pestova T.V., Shatsky I.N., Fletcher S.P., Jackson R.J., and Hellen C.U. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev. 12 (1998) 67-83
109. Sizova D.V., Kolupaeva V.G., Pestova T.V., Shatsky I.N., and Hellen C.U. Specific interaction of eukaryotic translation initiation factor 3 with the 5′ nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J. Virol. 72 (1998) 4775-4782
110. Judge A.D., Sood V., Shaw J.R., Fang D., McClintock K., and MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23 (2005) 457-462
111. Thomas C.E., Ehrhardt A., and Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev., Genet. 4 (2003) 346-358
112. Templeton N.S. Cationic liposome-mediated gene delivery in vivo. Biosci. Rep. 22 (2002) 283-295
113. Zimmermann T.S., Lee A.C., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., Harborth J., Heyes J.A., Jeffs L.B., John M., Judge A.D., Lam K., McClintock K., Nechev L.V., Palmer L.R., Racie T., Rohl I., Seiffert S., Shanmugam S., Sood V., Soutschek J., Toudjarska I., Wheat A.J., Yaworski E., Zedalis W., Koteliansky V., Manoharan M., Vornlocher H.P., and MacLachlan I. RNAi-mediated gene silencing in non-human primates. Nature 441 (2006) 111-114
114. McCaffrey A.P., Meuse L., Pham T.T., Conklin D.S., Hannon G.J., and Kay M.A. RNA interference in adult mice. Nature 418 (2002) 38-39
115. Liu F., Song Y., and Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6 (1999) 1258-1266
116. Zhang G., Gao X., Song Y.K., Vollmer R., Stolz D.B., Gasiorowski J.Z., Dean D.A., and Liu D. Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther. 11 (2004) 675-682
117. Wang Q., Contag C.H., Ilves H., Johnston B.H., and Kaspar R.L. Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model. Mol. Ther. 12 (2005) 562-568
118. Kim M., Shin D., Kim S.I., and Park M. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Virus Res. 122 (2006) 1-10
119. Toumi H., Hegge J., Subbotin V., Noble M., Herweijer H., Best T.M., and Hagstrom J.E. Rapid intravascular injection into limb skeletal muscle: a damage assessment study. Mol. Ther. 13 (2006) 229-236
120. Wu C.H., and Wu G.Y. Receptor-mediated delivery of foreign genes to hepatocytes. Adv. Drug Deliv. Rev. 29 (1998) 243-248
121. Oishi M., Nagasaki Y., Itaka K., Nishiyama N., and Kataoka K. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J. Am. Chem. Soc. 127 (2005) 1624-1625
122. Guidotti L.G., Matzke B., Schaller H., and Chisari F.V. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69 (1995) 6158-6169
123. Uprichard S.L., Boyd B., Althage A., and Chisari F.V. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 773-778
124. Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M., Elbashir S., Geick A., Hadwiger P., Harborth J., John M., Kesavan V., Lavine G., Pandey R.K., Racie T., Rajeev K.G., Rohl I., Toudjarska I., Wang G., Wuschko S., Bumcrot D., Koteliansky V., Limmer S., Manoharan M., and Vornlocher H.P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (2004) 173-178
125. Morrissey D.V., Blanchard K., Shaw L., Jensen K., Lockridge J.A., Dickinson B., McSwiggen J.A., Vargeese C., Bowman K., Shaffer C.S., Polisky B.A., and Zinnen S. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41 (2005) 1349-1356
126. Kawabata K., Takakura Y., and Hashida M. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 12 (1995) 825-830
127. Harborth J., Elbashir S.M., Vandenburgh K., Manninga H., Scaringe S.A., Weber K., and Tuschl T. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13 (2003) 83-105
128. Hall A.H., Wan J., Shaughnessy E.E., Ramsay Shaw B., and Alexander K.A. RNA interference using boranophosphate siRNAs: structure-activity relationships. Nucleic Acids Res. 32 (2004) 5991-6000
129. Chiu Y.L., and Rana T.M. siRNA function in RNAi: a chemical modification analysis. RNA 9 (2003) 1034-1048
130. Braasch D.A., Jensen S., Liu Y., Kaur K., Arar K., White M.A., and Corey D.R. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42 (2003) 7967-7975
131. Czauderna F., Fechtner M., Dames S., Aygun H., Klippel A., Pronk G.J., Giese K., and Kaufmann J. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31 (2003) 2705-2716
132. Fedorov Y., Anderson E.M., Birmingham A., Reynolds A., Karpilow J., Robinson K., Leake D., Marshall W.S., and Khvorova A. Off-target effects by siRNA can induce toxic phenotype. RNA 12 (2006) 1188-1196
133. Jackson A.L., Burchard J., Leake D., Reynolds A., Schelter J., Guo J., Johnson J.M., Lim L., Karpilow J., Nichols K., Marshall W., Khvorova A., and Linsley P.S. Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA 12 (2006) 1197-1205
134. Jackson A.L., Burchard J., Schelter J., Chau B.N., Cleary M., Lim L., and Linsley P.S. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA 12 (2006) 1179-1187
135. Kariko K., Bhuyan P., Capodici J., and Weissman D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol. 172 (2004) 6545-6549
136. Sioud M., and Sorensen D.R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 312 (2003) 1220-1225
137. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., and Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5 (2003) 834-839
138. Kim D.H., Longo M., Han Y., Lundberg P., Cantin E., and Rossi J.J. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22 (2004) 321-325
139. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., Noronha A., Manoharan M., Akira S., de Fougerolles A., Endres S., and Hartmann G. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11 (2005) 263-270
140. Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348 (2005) 1079-1090
141. Judge A.D., Bola G., Lee A.C., and MacLachlan I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13 (2006) 494-505
142. Snove Jr. O., and Rossi J.J. Expressing short hairpin RNAs in vivo. Nat. Methods 3 (2006) 689-695
143. Okuse C., Rinaudo J.A., Farrar K., Wells F., and Korba B.E. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. Antivir. Res. 65 (2005) 23-34
144. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
145. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., and Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006) 537-541
146. Hamazaki H., Ujino S., Miyano-Kurosaki N., Shimotohno K., and Takaku H. Inhibition of hepatitis C virus RNA replication by short hairpin RNA synthesized by T7 RNA polymerase in hepatitis C virus subgenomic replicons. Biochem. Biophys. Res. Commun. 343 (2006) 988-994
147. Wakita T., Taya C., Katsume A., Kato J., Yonekawa H., Kanegae Y., Saito I., Hayashi Y., Koike M., and Kohara M. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J. Biol. Chem. 273 (1998) 9001-9006